16 August 2021
New research from the University of Oxford and the UK Centre for Ecology & Hydrology, published today in Frontiers in Public Health, uses mathematical modelling to determine the most equitable way to share vaccines between nations.
Vaccines provide a route to achieving high levels of immunity against SARS-CoV-2 across populations, and provide a route to reopening economies, tourism, and livelihoods. However, vaccine resources amongst nations are unequal, which raises questions – both mathematical and ethical – about how best to share vaccines.
Researchers have developed a simple disease model, mapping travel between two nations and asking what the optimal way to deliver vaccinations is, assuming Nation A is producing vaccine and Nation B isn’t.
Even with extensive travel, Nation A can minimize deaths by simply retaining vaccine and aiming to fully inoculate its population. However, if the goal is minimising total deaths across all nations, by not initially sharing vaccines between nations in order to protect the population of Nation A, this causes more deaths in Nation B than lives saved in Nation A.
This paper raises important ethical issues about the imbalance in the health impact of vaccine provision across different countries.
Lead author, Dr Chris Huntingford of the UK Centre for Ecology & Hydrology (UKCEH) said ‘For any nation producing a vaccine, the way to minimise deaths in that country is to retain them and inoculate as many citizens as possible. However, if that nation approaches herd immunity, then overall more lives will be saved by sharing vaccines with other countries.’
Senior author, Prof Mike Bonsall (Dept of Zoology) said ‘Our work raises important issues on the quantitative nature of vaccination strategies and how to share vaccines. More importantly, it raises ethical issues on the value of lives between nations and argues for greater attention in vaccine sharing policies.’
Prof Bonsall is continuing to work on mathematical models about vaccine and lockdown strategies.
Notes to editors:
For more information contact Rob Ashley, Strategic Communications (Research & Innovation)Email: email@example.com
Professor Michael Bonsall (Michael.firstname.lastname@example.org)
Professor Chris Huntingford (email@example.com)
The full paper, Optimal COVID-19 vaccine sharing between two nations that also have extensive Travel Exchanges:
About Oxford University
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the fifth year running, and at the heart of this success is our ground-breaking research and innovation.
Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions. Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 170 new companies since 1988. Over a third of these companies have been created in the past three years.